zanamivir has been researched along with Hematologic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguado, JM; Díaz-Pedrochea, C; Escalante, F; Folgueira, D; Grande, C; Lizasoain, M; López-Medrano, F; Lumbreras, C; Sanz-Gallardo, I | 1 |
| Carrington, D; Clark, A; Johny, AA; Marks, DI; Oakhill, A; Price, N | 1 |
1 trial(s) available for zanamivir and Hematologic Neoplasms
| Article | Year |
|---|---|
The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Antiviral Agents; Female; Guanidines; Hematologic Neoplasms; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Male; Myelodysplastic Syndromes; Pyrans; Sialic Acids; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Zanamivir | 2002 |
1 other study(ies) available for zanamivir and Hematologic Neoplasms
| Article | Year |
|---|---|
[Nosocomial outbreak of influenza in high-risk hematological patients. Efficacy of control measures and the use of zanamivir].
Topics: Antiviral Agents; Cross Infection; Guanidines; Hematologic Neoplasms; Humans; Immunocompromised Host; Infection Control; Influenza A virus; Influenza, Human; Pyrans; Risk Factors; Sialic Acids; Zanamivir | 2006 |